Thursday, April 18, 2013

J&J Wins Its First Trial Over ASR


Johnson & Johnson gained a major victory in defending its subsidiary DePuy. The behomoth corporation succesfully defended at trial an Illinois woman’s claim she was harmed by a defectively designed metal-on-metal hip implant. The case is Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County (Chicago).

The jury of seven women and five men in state court in Chicago deliberated for slightly more than a day before returning its verdict in favor of DePuy Orthopaedics Inc. Plaintiff Carol Strum’s lawyers had asked the jury for an award of at least $5 million.

Jurors had sent a note during the deliberations to Cook County Circuit Judge Deborah Mary Dooling, who presided over the five-week trial, asking if they must be unanimous in their verdict. It appears that the jurors could not reach a unanimous verdict as polling of the panel after the verdict revealed that four jurors wanted to side with the injured Plaintiff.

Strum’s case was the second to go trial of almost 11,000 filed in the United States. The J&J unit was hit with a $8.3 million verdict in compensatory damages by a Los Angeles jury that found the design of its ASR XL hip implant was defective and that the company had properly warned of associated risks. The jury rejected punitive damages in that case.

Johnson & Johnson, based in New Brunswick, New Jersey, is the world’s largest seller of health-care products. J&J recalled the implants in August 2010 after an estimated 93,000 were sold because it said 12 percent failed within five years. Data last year showed 44 percent failed in Australia within seven years. Analysts have said the cases could cost J&J billions of dollars.

Details of the Case

The Plaintiff, Carol, Strum, was a 54-year-old nurse, who had an ASR XL implanted in her in 2008. It was replaced three years later. While her attorneys told jurors the chromium and cobalt implant shed metal into her body, poisoning tissue and sending metal ions into her blood stream, defense lawyers argued Strum had a hyper-sensitivity to the implant and that she got no pain relief when it was replaced with a different device. Defense attorneys also argued that DePuy’s product was not defectively designed.

Needless to say, the jury rejected Strum’s request that they impose punitive damages.

About 500 of the cases against DePuy are pending in Illinois. It is expected that at least one more case in Illinois will try this year

The verdicts are now evened up: one for the plaintiffs and one for the defendants in the "Bellwether
Trials". The Bellwether Trials are designed to gauge the settlement ranges on the remaining 11,000
cases still pending. Since each side already has a victory under its belt, there is sure to be more
cases brought in front of juries to see exactly where the public's perception is as to DePuy's liability
in the timing of the recall.